Janux Therapeutics (JANX) Assets Average: 2021-2025
Historic Assets Average for Janux Therapeutics (JANX) over the last 4 years, with Sep 2025 value amounting to $1.0 billion.
- Janux Therapeutics' Assets Average rose 48.36% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 48.36%. This contributed to the annual value of $721.0 million for FY2024, which is 93.70% up from last year.
- Per Janux Therapeutics' latest filing, its Assets Average stood at $1.0 billion for Q3 2025, which was down 1.25% from $1.0 billion recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Assets Average registered a high of $1.1 billion during Q1 2025, and its lowest value of $347.2 million during Q2 2023.
- Moreover, its 3-year median value for Assets Average was $690.2 million (2024), whereas its average is $670.5 million.
- As far as peak fluctuations go, Janux Therapeutics' Assets Average dropped by 7.89% in 2023, and later surged by 128.94% in 2024.
- Quarterly analysis of 5 years shows Janux Therapeutics' Assets Average stood at $385.5 million in 2021, then dropped by 4.04% to $369.9 million in 2022, then increased by 3.72% to $383.6 million in 2023, then surged by 128.94% to $878.3 million in 2024, then surged by 48.36% to $1.0 billion in 2025.
- Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.1 billion during Q1 2025.